Ecolab
ECL
$276.18
+1.69%
Ecolab, Inc. is a global leader in water, hygiene, and infection prevention solutions, providing cleaning, sanitation, and water management products and services to industries including industrial manufacturing, data centers, hospitality, healthcare, and life sciences. As the world's largest player in this niche, Ecolab differentiates itself through its comprehensive service model and strong brand trust, with a dominant US market presence and expanding international footprint. The current investor narrative centers on Ecolab's strategic pivot into the high-growth AI data center cooling market, highlighted by its $4.75 billion acquisition of CoolIT, which has sparked both excitement and skepticism regarding price and timing, while the company continues to deliver steady revenue growth and margin expansion.…
ECL
Ecolab
$276.18
Investment Opinion: Should I buy ECL Today?
Based on the analysis, ECL is rated a Buy. The consensus recommendation is 'Buy' with an average target price of $324.95, implying a +16.4% upside. The thesis is that Ecolab's core business is growing steadily, and the CoolIT acquisition provides a new growth vector in AI cooling, which could drive earnings above current expectations.
Sign up to view all
ECL 12-Month Price Forecast
The AI assessment is bullish with medium confidence. Ecolab's fundamentals are solid, with accelerating revenue growth and margin expansion. The CoolIT acquisition provides a tangible catalyst for future growth, though execution risks remain. The stock's underperformance relative to the market suggests potential for catch-up, and the analyst consensus supports upside. However, the high valuation and debt levels warrant caution. If the company delivers on its growth promises and the acquisition integrates well, the stock could outperform; otherwise, it may remain range-bound. Monitoring quarterly earnings and CoolIT integration progress will be key to confirming the bullish stance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ecolab's 12-month outlook, with a consensus price target around $324.95 and implied upside of +17.7% versus the current price.
Average Target
$324.95
0 analysts
Implied Upside
+17.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$295 - $360
Analyst target range
Ecolab is covered by 21 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.54 (where 1 is Strong Buy and 5 is Sell). The average target price is $324.95, implying a +16.4% upside from the current price of $279.28. The distribution of ratings is bullish, with no Sell ratings and a majority of Buy or Outperform ratings, as evidenced by recent actions from Deutsche Bank (Buy), RBC Capital (Outperform), and Citigroup (Buy). This strong consensus suggests analysts are confident in the company's growth trajectory, particularly following the CoolIT acquisition and continued margin improvements.
Bulls vs Bears: ECL Investment Factors
Ecolab presents a mixed picture: strong fundamentals with accelerating revenue growth and margin expansion, but the stock has underperformed the market and trades at a premium valuation. The bull case rests on the successful integration of CoolIT and continued margin gains, while the bear case highlights the high price paid for growth and the risk of execution missteps. Currently, the evidence slightly favors the bulls given the strong analyst consensus and tangible growth catalysts, but the key tension is whether the CoolIT acquisition will deliver the expected synergies and revenue growth to justify the premium valuation. If integration fails or growth decelerates, the stock could face significant downside.
Bullish
- Strong Revenue Growth: Q1 2026 revenue grew 10.04% YoY to $4.066 billion, accelerating from the prior quarter's 4.25% growth. This broad-based expansion across all segments indicates healthy demand for Ecolab's water, hygiene, and infection prevention solutions.
- Margin Expansion Potential: Operating margin improved to 18.1% in Q1 2026 from 15.9% in Q1 2025, reflecting operational leverage and cost discipline. The forward PE of 29.65x implies the market expects continued earnings growth of ~20.8%, supported by these margin gains.
- AI Data Center Cooling Catalyst: The $4.75 billion CoolIT acquisition positions Ecolab in the high-growth AI data center cooling market, a strategic pivot that could drive significant future revenue. Analysts have responded positively, with Deutsche Bank, RBC Capital, and Citigroup all issuing Buy or Outperform ratings.
- Strong Analyst Consensus: With 21 analysts, the consensus is 'Buy' with a mean recommendation score of 1.54 (close to Strong Buy). The average target price of $324.95 implies a +16.4% upside from the current price of $279.28, and no Sell ratings exist.
Bearish
- Underperformance vs. Market: ECL's 1-year price change of +1.58% significantly lags the S&P 500's +18.65% gain. Relative strength over 1 year is -17.07%, indicating persistent investor skepticism and a lack of momentum.
- High Valuation Multiples: Trailing PE of 35.81x and forward PE of 29.65x are premium to the broader market. EV/EBITDA of 24.02x and PS of 4.62x suggest the stock is priced for perfection, leaving little room for disappointment.
- CoolIT Acquisition Risks: The $4.75 billion price tag for CoolIT is substantial, and the stock declined following the announcement, indicating market skepticism about the price and timing. Integration risks and potential overpayment could weigh on returns.
- High Debt Levels: Debt-to-equity ratio of 0.97 indicates significant leverage, which could strain cash flows if interest rates remain elevated. The company's interest expense of $72.7 million in Q1 2026 is a notable burden.
ECL Technical Analysis
Ecolab's stock has exhibited a recovery trend over the past year, with a 1-year price change of +1.58%, though this significantly lags the S&P 500's +18.65% gain. The current price of $279.28 sits at 54.2% of the 52-week range (between $243.15 low and $309.27 high), indicating the stock is closer to the lower half of its yearly range. This positioning suggests the market has not fully embraced the stock's recovery, potentially offering value if the underlying fundamentals continue to improve, but also reflecting persistent headwinds that have kept it from approaching its highs.
Beta
0.89
0.89x market volatility
Max Drawdown
-20.3%
Largest decline past year
52-Week Range
$243-$309
Price range past year
Annual Return
+0.5%
Cumulative gain past year
| Period | ECL Return | S&P 500 |
|---|---|---|
| 1m | -0.8% | -1.1% |
| 3m | +4.1% | +3.0% |
| 6m | +0.7% | +15.4% |
| 1y | +0.5% | +16.2% |
| ytd | +5.2% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ECL Fundamental Analysis
Ecolab's revenue trajectory remains solid, with Q1 2026 revenue of $4.066 billion, up 10.04% year-over-year from $3.695 billion in Q1 2025. This growth is consistent with the prior quarter's 4.25% YoY increase (Q4 2025 revenue of $4.196 billion vs. $4.005 billion in Q4 2024), indicating a stable, mid-single-digit to low-double-digit growth pattern. The company's Global Water segment is the largest revenue driver at $2.043 billion, followed by Global Institutional and Specialty at $1.511 billion, while Global Life Sciences ($200.9 million) and Global Pest Elimination ($310.8 million) contribute smaller but specialized streams. The growth is broad-based, with no single segment dragging overall performance, supporting a positive investment case.
Quarterly Revenue
$4.1B
2026-03
Revenue YoY Growth
+10.0%
YoY Comparison
Gross Margin
43.5%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ECL Overvalued?
Given Ecolab's positive net income, the price-to-earnings (PE) ratio is the most appropriate valuation metric. The trailing PE stands at 35.81x, while the forward PE is 29.65x, implying the market expects earnings growth of approximately 20.8% over the next year. This gap between trailing and forward multiples suggests investors are pricing in continued margin expansion and operational leverage, which is supported by the company's recent performance. The forward PE of 29.65x is below the trailing multiple, indicating that the market's growth expectations are not overly aggressive but rather reflect a reasonable outlook for the company's earnings power.
PE
35.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 25x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are notable. Ecolab carries a debt-to-equity ratio of 0.97, indicating substantial leverage that could become burdensome if interest rates stay high; interest expense was $72.7 million in Q1 2026. The company's reliance on continued margin expansion to justify its forward PE of 29.65x is a risk if input costs rise or pricing power weakens. Revenue growth, while solid at 10% YoY, is not explosive, and any slowdown could trigger multiple compression. Free cash flow of $1.87 billion TTM is positive but modest relative to the company's $80 billion market cap, limiting financial flexibility.